Sflee
2021-07-26
Nice
Philips second-quarter earnings beat forecast as pandemic fuels demand
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
1
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":800106321,"tweetId":"800106321","gmtCreate":1627283612963,"gmtModify":1633766538208,"author":{"id":3578558545565358,"idStr":"3578558545565358","authorId":3578558545565358,"authorIdStr":"3578558545565358","name":"Sflee","avatar":"https://static.tigerbbs.com/4cb3212d98ab3b2afad4ac0730e55856","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Nice</p></body></html>","htmlText":"<html><head></head><body><p>Nice</p></body></html>","text":"Nice","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/800106321","repostId":2154504955,"repostType":4,"repost":{"id":"2154504955","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1627278729,"share":"https://www.laohu8.com/m/news/2154504955?lang=&edition=full","pubTime":"2021-07-26 13:52","market":"us","language":"en","title":"Philips second-quarter earnings beat forecast as pandemic fuels demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2154504955","media":"Reuters","summary":"July 26 (Reuters) - Dutch health technology company Philips on Monday beat analysts' expectations wi","content":"<p>July 26 (Reuters) - Dutch health technology company Philips on Monday beat analysts' expectations with a jump in second-quarter core earnings to 532 million euros ($626 million), as the COVID-19 pandemic continued to spur demand for hospital equipment.</p>\n<p>Analysts polled by the company on average had expected adjusted earnings before interest, taxes and amortisation (EBITA) to rise to 519 million euros in April-June, up from 390 million euros a year earlier.</p>\n<p>Philips sells products ranging from toothbrushes to medical imaging systems, and is a main competitor of General Electric and Siemens Healthineers .</p>\n<p>Comparable sales increased 9%, beating an average expectation of a 7.3% rise. However, sales in its connected care division fell, dragged lower by its sleep and respiratory care business.</p>\n<p>The company booked an additional provision of 250 million euros, following an earlier provision in the first quarter of this year, as it works to repair and replace millions of sleep devices it recalled earlier in June.</p>\n<p>Last month, Philips recalled up to 4 million breathing devices and ventilators because of a foam part that might degrade and become toxic, potentially causing cancer.</p>\n<p>\"We are in discussions with the relevant regulatory authorities to obtain authorisation to start deploying the repair kits and replacement devices that we are producing,\" Philips Chief Executive Frans van Houten said in a statement.</p>\n<p>The U.S. Food and Drug Administration last week classified the recall of Philips' breathing devices and ventilators as the most serious type of recall, saying the use of these devices may cause serious injuries or death.</p>\n<p>The Amsterdam-based company confirmed its forecast of low- to mid-single-digit comparable sales growth for the whole of 2021.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Philips second-quarter earnings beat forecast as pandemic fuels demand</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPhilips second-quarter earnings beat forecast as pandemic fuels demand\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-26 13:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>July 26 (Reuters) - Dutch health technology company Philips on Monday beat analysts' expectations with a jump in second-quarter core earnings to 532 million euros ($626 million), as the COVID-19 pandemic continued to spur demand for hospital equipment.</p>\n<p>Analysts polled by the company on average had expected adjusted earnings before interest, taxes and amortisation (EBITA) to rise to 519 million euros in April-June, up from 390 million euros a year earlier.</p>\n<p>Philips sells products ranging from toothbrushes to medical imaging systems, and is a main competitor of General Electric and Siemens Healthineers .</p>\n<p>Comparable sales increased 9%, beating an average expectation of a 7.3% rise. However, sales in its connected care division fell, dragged lower by its sleep and respiratory care business.</p>\n<p>The company booked an additional provision of 250 million euros, following an earlier provision in the first quarter of this year, as it works to repair and replace millions of sleep devices it recalled earlier in June.</p>\n<p>Last month, Philips recalled up to 4 million breathing devices and ventilators because of a foam part that might degrade and become toxic, potentially causing cancer.</p>\n<p>\"We are in discussions with the relevant regulatory authorities to obtain authorisation to start deploying the repair kits and replacement devices that we are producing,\" Philips Chief Executive Frans van Houten said in a statement.</p>\n<p>The U.S. Food and Drug Administration last week classified the recall of Philips' breathing devices and ventilators as the most serious type of recall, saying the use of these devices may cause serious injuries or death.</p>\n<p>The Amsterdam-based company confirmed its forecast of low- to mid-single-digit comparable sales growth for the whole of 2021.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GE":"GE航空航天","PHG":"飞利浦"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2154504955","content_text":"July 26 (Reuters) - Dutch health technology company Philips on Monday beat analysts' expectations with a jump in second-quarter core earnings to 532 million euros ($626 million), as the COVID-19 pandemic continued to spur demand for hospital equipment.\nAnalysts polled by the company on average had expected adjusted earnings before interest, taxes and amortisation (EBITA) to rise to 519 million euros in April-June, up from 390 million euros a year earlier.\nPhilips sells products ranging from toothbrushes to medical imaging systems, and is a main competitor of General Electric and Siemens Healthineers .\nComparable sales increased 9%, beating an average expectation of a 7.3% rise. However, sales in its connected care division fell, dragged lower by its sleep and respiratory care business.\nThe company booked an additional provision of 250 million euros, following an earlier provision in the first quarter of this year, as it works to repair and replace millions of sleep devices it recalled earlier in June.\nLast month, Philips recalled up to 4 million breathing devices and ventilators because of a foam part that might degrade and become toxic, potentially causing cancer.\n\"We are in discussions with the relevant regulatory authorities to obtain authorisation to start deploying the repair kits and replacement devices that we are producing,\" Philips Chief Executive Frans van Houten said in a statement.\nThe U.S. Food and Drug Administration last week classified the recall of Philips' breathing devices and ventilators as the most serious type of recall, saying the use of these devices may cause serious injuries or death.\nThe Amsterdam-based company confirmed its forecast of low- to mid-single-digit comparable sales growth for the whole of 2021.","news_type":1},"isVote":1,"tweetType":1,"viewCount":49,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":4,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/800106321"}
精彩评论